Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
about
Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study.HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problemsSelecting a clinical intervention documentation system for an academic setting.Cost-outcome description of clinical pharmacist interventions in a university teaching hospitalEconomic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.Interprofessional collaborative care characteristics and the occurrence of bedside interprofessional rounds: a cross-sectional analysis.Impact of clinical pharmacist in an Indian Intensive Care Unit.Assessment of clinical pharmacy interventions in the intensive care unit.Outcome Assessment of Critical Care Pharmacist ServicesComputerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional study.A primer on critical care pharmacy services.Development of clinical pharmacy services for intensive care units in Korea.Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.Evaluation and justification of clinical pharmacy services.Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit.The Economic and Humanistic Burden of Severe Sepsis.Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review.Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions.Impact of the introduction of a specialist critical care pharmacist on the level of pharmaceutical care provided to the critical care unit.The perceived value of clinical pharmacy service provision by pharmacists and physicians: an initial assessment of family medicine and internal medicine providers.Variables Affecting Pharmacy Students' Patient Care Interventions during Advanced Pharmacy Practice Experiences.A multifaceted intervention to reduce drug-related complications in surgical patients.PROTECTED-UK - Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level.Implementation and progress of clinical pharmacy in the rational medication use in a large tertiary hospital.Interprofessional rhetoric and operational realities: an ethnographic study of rounds in four intensive care units.Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.Pharmacists' Research Contributions in the Fight against HIV/AIDs.Implementation of a school-wide clinical intervention documentation systemPharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare.Developing a Business Plan for Critical Care Pharmacy Services.Analysis of clinical interventions and the impact of pediatric pharmacists on medication error prevention in a teaching hospital.Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors.Evaluation of pharmaceutical care in a diabetes ward from China: a pre-and post-intervention study.Evaluating clinical pharmacy services on a surgical patient-care area: a nurses' satisfaction survey.Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.Severity and probability of harm of medication errors intercepted by an emergency department pharmacist.Role of the pharmacist in reducing healthcare costs: current insights.
P2860
Q33734676-4D1505C7-3A8F-4013-9939-D9B7CB1469ACQ33896762-1F926645-C7D8-4C56-ADEC-B8516DE8ECB9Q34774956-18CBC282-78CC-4B18-9ECB-29A127E69553Q35151219-FBD5019E-FD1B-4E22-91E2-7E41116DE594Q35251222-E2CE5FFE-E6DB-447B-8731-42908BD7993EQ35559211-B0A1E059-E5DC-4E27-A557-008C38BFBCD5Q36120500-AD4EAE8E-80E3-47C0-A7DA-30EE3C3B805CQ36737393-6E47E4CD-E168-44D7-9F97-8DFFD57AB781Q37096132-C7DA784D-9CF4-4F7B-A039-D33B36A0D2BBQ37167673-C54F6F36-45DE-4B1E-B45F-C04DE72D89B0Q37320439-CE6BD4C0-9C42-46CC-96AF-EA7111D6AEFDQ37328821-ED68D416-DCD2-47BC-9DEC-97A84F9DAFEAQ37514893-D2F954B3-4FBD-47F2-8893-9D34218A7AEAQ37543919-4E8D0762-F090-4131-B968-2ADC7AFFCFECQ37639323-B3C0F11E-7C3D-44FF-8241-73A830855FE3Q37987093-EE914C2C-2039-40E0-B976-6BAB51A32DEBQ38455028-52FE14FA-C709-48BC-8408-E33767B781B1Q38663766-572BB983-D9A7-4C66-85FD-56A4C3D194A9Q38679025-42581EEF-ACE9-440A-A097-2C37321E6090Q38700139-213C5CDB-7567-4FC9-B939-8C4ED806E148Q38806804-BA97C19A-A2AE-413F-A49D-DE299B143E8BQ38809224-357E4DC2-7D05-4FEB-B2E0-E2E91987FBD7Q38964931-CF116768-A1FB-4F31-A2F1-27F1A2CCB5FDQ38971740-5A4C09E5-8835-40A3-AD9F-BC21416EE626Q40113905-331B6E88-5FAB-4020-8596-F52DF35BFFD6Q40171565-F8158323-87E9-49E8-AB20-4A214C9CAEFBQ40672595-9A53D6EE-9395-4BC8-BC3A-F2044D3151BBQ41530533-0CBD03B1-18C7-4FD8-B488-CFA5A73D1E46Q41818108-780C5037-AB1A-4FB8-BD17-7D7BA2C57C86Q42120363-79C6DE85-9E4C-4353-986C-D6A757B83894Q42793748-AC8B2CAD-BA73-4905-B376-569E13E6C89CQ43195867-E35D122A-B620-48B2-9F33-0DC1B6886414Q43803597-3E9534FB-E6FD-4433-A303-6C492AD0EDC2Q43986306-5BCF5663-27D2-426B-93E0-A862A88E2FD0Q44218199-156A5CE7-96F3-4F5D-B1C7-4E0E17714B8DQ44495381-CCE4AEDA-EC2E-4CE6-A7B3-27553152B59CQ45332063-C9278DDC-8FF3-4EBE-8E82-E6FBB2DB11B6Q45812223-15B3EB11-3683-4DD4-A6D9-6AFAD7290FFFQ46899665-D2FE5041-719E-47E7-81F4-87977ADEEA6BQ47721160-AA634A37-761F-4C18-A346-D7EE26951A26
P2860
Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost implications of and poten ...... of a critical care pharmacist.
@en
Cost implications of and poten ...... of a critical care pharmacist.
@nl
type
label
Cost implications of and poten ...... of a critical care pharmacist.
@en
Cost implications of and poten ...... of a critical care pharmacist.
@nl
prefLabel
Cost implications of and poten ...... of a critical care pharmacist.
@en
Cost implications of and poten ...... of a critical care pharmacist.
@nl
P2093
P356
P1476
Cost implications of and poten ...... of a critical care pharmacist.
@en
P2093
Brian J Kopp
Brian L Erstad
Jeremiah J Duby
Melinda Mrsan
P304
P356
10.2146/AJHP060674
P577
2007-12-01T00:00:00Z